ethanolamine has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vecchini, A | 1 |
| Binaglia, L | 1 |
| Di Nardo, P | 1 |
| Minieri, M | 1 |
| Tallarida, G | 1 |
1 other study available for ethanolamine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Phospholipid base exchange enzyme activity in sarcolemmal membranes from the heart of cardiomyopathic hamsters.
Topics: Animals; Cardiomyopathy, Hypertrophic; Cricetinae; Ethanolamine; Ethanolamines; Mesocricetus; Myocar | 1992 |